
rapamycinPharmaceutical Reference StandardsIntermediates and building blockspharmaceutical standards
Sirolimus Isomer A
- Catalogue No.
- CSL-185280
- CAS No.
- Not assigned
- Molecular formula
- C51H79NO13
- Molecular weight
- 914.19
- Parent drug
- rapamycin
- Product type
- Pharmaceutical Reference Standards, Intermediates and building blocks, pharmaceutical standards, Fine Chemicals
Quick quote · CSL-185280Price and availability on request
ISO 17034:2016 · GLPTell us the quantity you need, from a few milligrams upwards, and we reply within 24 hours with price, availability and delivery time.
Need documents or a larger lot? Use the full quote form
Synonyms
- 10,21-Dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,13,14,21,22,23,24,25,26,32,33,34,34a-tetradecahydro-3H-pyrido[2,1-c][1]oxa[4]azacyclohentriacontine-1,5,11,27,28,29(4H,6H,12H,31H)-hexaone
- (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R)-9,23-dihydroxy-3-((R)-1-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)propan-2-yl)-
- (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,34aS)-9,23-dihydroxy-3-((R)-1-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)propan-2-yl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,13,14,21,22,23,24,25,26,32,33,34,34a-tetradecahydro-3H-pyrido[2,1-c][1]oxa[4]azacyclohentriacontine-1,5,11,27,28,29(4H,6H,12H,31H)-hexaone
More rapamycin products
All 67 →![Chemical structure of (19E/Z)-seco-[4-O-[2-Hydroxy(ethyl)-d4]] Rapamycin Sodium Salt](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F19EZ-seco-4-O-2-Hydroxyethyl-d4-Rapamycin-Sodium-Salt.png&w=3840&q=75)
(19E/Z)-seco-[4-O-[2-Hydroxy(ethyl)-d4]] Rapamycin Sodium SaltCSL-177150
![Chemical structure of (3R,9aS)-3-Hydroxy-3-((2R,3R,6S)-2-hydroxy-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxodocosa-3,5,7,15,19-pentaen-1-yl)-3-methyltetrahydro-2H-pyran-2-yl)tetrahydropyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3R9aS-3-Hydroxy-3-2R3R6S-2-hydroxy-6-2S3E5E7E9S11R13R14R15E17R19E21R-14-hydroxy-22-1S3R4R-4-hydroxy-3-methoxycyclohexyl-213-dimethoxy-3911151721-hexam.png&w=3840&q=75)
(3R,9aS)-3-Hydroxy-3-((2R,3R,6S)-2-hydroxy-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxodocosa-3,5,7,15,19-pentaen-1-yl)-3-methyltetrahydro-2H-pyran-2-yl)tetrahydropyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dioneCSL-192692

(7R)-Rapamycin157182-37-1
![Chemical structure of (9aS)-3-Hydroxy-3-((2R,3R,6S)-2-hydroxy-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E)-14-hydroxy-2,13-dimethoxy-3,9,11,15-tetramethyl-12,17-dioxooctadeca-3,5,7,15-tetraen-1-yl)-3-methyltetrahydro-2H-pyran-2-yl)tetrahydropyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F9aS-3-Hydroxy-3-2R3R6S-2-hydroxy-6-2S3E5E7E9S11R13R14R15E-14-hydroxy-213-dimethoxy-391115-tetramethyl-1217-dioxooctadeca-35715-tetraen-1-yl-3-methylte.png&w=3840&q=75)
(9aS)-3-Hydroxy-3-((2R,3R,6S)-2-hydroxy-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E)-14-hydroxy-2,13-dimethoxy-3,9,11,15-tetramethyl-12,17-dioxooctadeca-3,5,7,15-tetraen-1-yl)-3-methyltetrahydro-2H-pyran-2-yl)tetrahydropyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dioneCSL-193984

